Low-and middle-income countries (LMICs) are increasingly using economic evaluation to inform decisions about which health care interventions might be funded publicly, given public sector finance and resource constraints (Shillcutt et al., 2009). Typically, economic evaluation has been used to evaluate health care interventions under the driving force of health technology assessment (HTA) programmes (Oortwijn et al., 2010). This is similar to the pattern in high-income countries (HICs), where the use of economic evaluation for HTA